Momordica charantia (Indian and Chinese bitter melon) extracts inducing apoptosis in human lung cancer cell line A549 via ROS-mediated mitochodria injury by Thiagarajan, Siroshini et al.
Momordica charantia (Indian and Chinese bitter melon) extracts inducing apoptosis in 
human lung cancer cell line A549 via ROS-mediated mitochodria injury 
 
ABSTRACT 
Lung cancer is the leading cause of cancer related deaths worldwide with about 40% 
occurring in developing countries. The two varieties of Momordica charantia, which are 
Chinese and Indian bitter melon, have been subjected to antiproliferative activity in human 
non-small cell lung cells A549. The A549 cells were treated with hot and cold aqueous 
extraction for both the bitter melon varieties, and the antiproliferative activity was evaluated 
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The apoptotic 
mechanism of action on A549 human lung cancer cells was evaluated first morphologically 
using Hoechst 33358, and cytoskeleton staining using Filamentous-actin (F-actin) 
cytoskeleton FICT and DAPI followed by caspase-3/7, reactive oxygen species (ROS), and 
p53 activity. Chinese hot aqueous extraction (CHA) exhibited potent antiproliferative activity 
against A549 human lung cancer cells. The morphological analysis of mitochondria 
destruction and the derangement of cytoskeleton showed apoptosis-inducing activity. CHA 
increased the caspase-3/7 activity by 1.6-fold and the ROS activity by 5-fold. Flow 
cytometric analysis revealed 34.5% of apoptotic cells significantly (p<0.05) compared to 
cisplatin-treated A549 human cancer cells. CHA is suggested to induce apoptosis due to their 
rich bioactive chemical constituents. These findings suggest that the antiproliferative effect of 
CHA was due to apoptosis via ROS-mediated mitochondria injury. 
